Sparse spectral graph analysis and its application to gastric cancer drug resistance-specific molecular interplays
Heewon Park1, Satoru Miyano2,3
1School of Mathematics, Statistics and Data Science, Sungshin Women's University, Seoul, Republic of Korea.
Abstract:
Uncovering acquired drug resistance mechanisms has garnered considerable attention as drug resistance leads to treatment failure and death in patients with cancer. Although several bioinformatics studies developed various computational methodologies to uncover the drug resistance mechanisms in cancer chemotherapy, most studies were based on individual or differential gene expression analysis. However the single gene-based analysis is not enough, because perturbations in complex molecular networks are involved in anti-cancer drug resistance mechanisms. The main goal of this study is to reveal crucial molecular interplay that plays key roles in mechanism underlying acquired gastric cancer drug resistance. To uncover the mechanism and molecular characteristics of drug resistance, we propose a novel computational strategy that identified the differentially regulated gene networks. Our method measures dissimilarity of networks based on the eigenvalues of the Laplacian matrix. Especially, our strategy determined the networks' eigenstructure based on sparse eigen loadings, thus, the only crucial features to describe the graph structure are involved in the eigenanalysis without noise disturbance. We incorporated the network biology knowledge into eigenanalysis based on the network-constrained regularization. Therefore, we can achieve a biologically reliable interpretation of the differentially regulated gene network identification. Monte Carlo simulations show the outstanding performances of the proposed methodology for differentially regulated gene network identification. We applied our strategy to gastric cancer drug-resistant-specific molecular interplays and related markers. The identified drug resistance markers are verified through the literature. Our results suggest that the suppression and/or induction of COL4A1, PXDN and TGFBI and their molecular interplays enriched in the Extracellular-related pathways may provide crucial clues to enhance the chemosensitivity of gastric cancer. The developed strategy will be a useful tool to identify phenotype-specific molecular characteristics that can provide essential clues to uncover the complex cancer mechanism.
Insights
This study introduces a new computational method to identify key molecular networks driving acquired drug resistance in gastric cancer. The findings highlight specific genes and pathways that could improve chemotherapy effectiveness.
Area of Science:
- Bioinformatics
- Computational Biology
- Cancer Research
Background:
- Acquired drug resistance in cancer chemotherapy leads to treatment failure and mortality.
- Existing bioinformatics studies often rely on single gene expression analysis, which is insufficient for complex molecular networks.
- Understanding complex molecular interplay is crucial for uncovering drug resistance mechanisms.
Purpose of the Study:
- To reveal crucial molecular interplay underlying acquired gastric cancer drug resistance.
- To develop a novel computational strategy for identifying differentially regulated gene networks.
- To identify reliable drug resistance markers and therapeutic targets in gastric cancer.
Main Methods:
- Proposed a novel computational strategy to identify differentially regulated gene networks.
- Measured network dissimilarity using eigenvalues of the Laplacian matrix.
- Incorporated network biology knowledge via network-constrained regularization for biologically interpretable results.
Main Results:
- The novel methodology demonstrated outstanding performance in identifying differentially regulated gene networks via Monte Carlo simulations.
- Applied the strategy to gastric cancer, identifying specific molecular interplays and markers.
- Validated identified drug resistance markers through existing literature.
Conclusions:
- Suppression or induction of COL4A1, PXDN, and TGFBI, and their associated extracellular pathways, may enhance gastric cancer chemosensitivity.
- The developed computational strategy is a valuable tool for identifying phenotype-specific molecular characteristics.
- This approach provides essential clues for uncovering complex cancer mechanisms and developing targeted therapies.
